ICON Public Limited Company Stock Performance Sees Decline at Close of Market
January 3, 2023
Trending News 🌧️
ICON ($NASDAQ:ICLR) Public Limited Company is a leading provider of comprehensive solutions in the field of IT services and solutions. As of today, ICON Public Limited Company’s stock is traded on the NASDAQ stock exchange. This decline in stock performance can be attributed to a number of factors, including overall market volatility, the impact of the coronavirus pandemic, and changes in the company’s financials. Those interested in monitoring the stock performance of ICON Public Limited Company should roll up their sleeves and get ready for some intense analysis. The primary focus should be on understanding the company’s financials. Analysts should be looking out for any changes in revenue, profits, debt levels, and other financial indicators that may be affecting the company’s stock performance.
It is also important to keep an eye out for any announcements made by the company, as these can also have a direct impact on the stock price. In addition to analyzing the company’s financials, analysts should also pay close attention to external factors that may be affecting ICON Public Limited Company’s stock performance. This includes evaluating changes in the overall market climate, industry trends, geopolitical events, and more. Analysts must take into account both internal and external factors to get a better picture of the company’s current state. By doing so, investors will be better equipped to make informed decisions when it comes to investing in ICON Public Limited Company’s stock.
Price History
At the time of writing, news sentiment surrounding the company was mostly negative. Specifically, ICON PUBLIC‘s stock opened at $194.8 and closed at $193.2, down by 0.8% from the prior closing price of $194.8. The company’s stock had been on a downward trend since mid-April, and this decline has only exacerbated it. Investors should take this decline into account when assessing the overall performance of ICON PUBLIC’s stock.
While this decline could be a sign of trouble for the company, it is important to remember that stock prices are always fluctuating, and it is possible that the decline could be reversed in the near future. For those who are invested in ICON PUBLIC’s stock, it is important to keep up with the latest news and developments from the company in order to make informed decisions about their investments. It is important for investors to do their research and keep up with the latest news and developments from the company in order to make informed decisions. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Icon Public. More…
| Total Revenues | Net Income | Net Margin |
| 7.66k | 464.33 | 7.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Icon Public. More…
| Operations | Investing | Financing |
| 912.56 | -146 | -1.16k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Icon Public. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 17.13k | 8.89k | 99.92 |
Key Ratios Snapshot
Some of the financial key ratios for Icon Public are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 40.6% | 26.0% | 8.5% |
| FCF Margin | ROE | ROA |
| 10.2% | 5.0% | 2.4% |
VI Analysis
ICON PUBLIC is a high risk investment according to the VI Risk Rating. The ratings are based on an analysis of the company’s fundamentals, which reflect its long term potential. The VI App has identified five risk warnings in the income sheet, balance sheet, cashflow statement, non financial and financial journal. Risk warnings indicate that the company may not be able to sustain its current performance or is losing value over time. They could also mean that the company’s management is not taking proper care of their resources or not following up with the necessary steps to ensure their business is running as smoothly as possible. The most important thing to remember when investing in a high-risk company is to ensure that you have done your due diligence and have a solid understanding of what you are getting yourself into. It is important to take into account all the risks associated with investing in ICON PUBLIC and to be aware of any potential risks that may arise in the future. Finally, it is essential to be sure that you are comfortable with the amount of money that you are investing in ICON PUBLIC. As with any investment, it is important to make sure that you are comfortable with the amount of money that you are investing and understand the risks associated with it. More…
VI Peers
Icon PLC, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, offers a comprehensive portfolio of services. The company has over 30 years of experience in clinical research and has conducted over 10,000 clinical trials in over 100 countries. Icon has a team of over 8,000 employees, including 1,200 clinical research professionals. The company’s main competitors are Bioqual Inc, Imagion Biosystems Ltd, and Aclaris Therapeutics Inc.
– Bioqual Inc ($OTCPK:BIOQ)
The company’s market cap is 5.24M as of 2022 and its ROE is 265.57%. The company is engaged in the development of therapeutics to treat patients with serious and life-threatening diseases.
– Imagion Biosystems Ltd ($ASX:IBX)
Imagion Biosystems Ltd is a medical technology company that develops and commercializes molecular imaging products for the early detection of cancer. The company has a market capitalization of $31.4 million and a return on equity of -59.36%. Imagion Biosystems’ products are based on magnetic nanoparticles that are injected into the body and selectively bind to cancer cells. The nanoparticles are then detected using a magnetic resonance imaging (MRI) scanner, which allows for the early detection of cancer.
– Aclaris Therapeutics Inc ($NASDAQ:ACRS)
Aclaris Therapeutics Inc is a biopharmaceutical company that focuses on the development and commercialization of drugs for the treatment of dermatological and immunological disorders. The company has a market cap of 1.01B as of 2022 and a return on equity of -25.42%. Aclaris Therapeutics Inc is headquartered in Malvern, Pennsylvania.
Summary
Investors in ICON Public Limited Company have seen their stock performance decline at close of market. Recent sentiment surrounding the company appears to be largely negative. As a result, it is important for investors to do their research and investigate the current state of the company before investing. Factors to consider include financials, the company’s competitive position, the management team, and macroeconomic trends.
Additionally, investors should be aware of any regulatory changes that may impact the stock price. With careful analysis and understanding of the risks, investors may be able to make an informed decision about whether to invest in ICON Public.
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
